Insights

Innovation in Pharmaceuticals Novartis France focuses on developing innovative medicines that significantly impact patient health, presenting opportunities to offer advanced healthcare solutions and integrated technology services to enhance their R&D and manufacturing processes.

Digital Therapeutics Collaboration The company's partnership with Tilak Healthcare on mobile medical applications indicates a readiness to incorporate digital health solutions, opening avenues for sales in telemedicine platforms, remote monitoring tools, and digital therapeutics integration.

Facility Expansion Strategy Recent investments in expanding research and production facilities in Indiana and France demonstrate ongoing growth and capacity-building, providing potential for supplying cutting-edge manufacturing equipment, laboratory technologies, and maintenance services.

Acquisition & Growth The acquisition of The Medicines Company and CellforCure highlights Novartis’ aggressive growth through strategic acquisitions, suggesting a need for integration software, compliance solutions, and advanced cell and gene therapy manufacturing technologies.

Technological Sophistication Utilization of advanced tech stacks such as Qlik Sense, SAP, Python, and C++ signals a high-tech operational environment, offering potential sales opportunities in enterprise software, analytics solutions, and bespoke IT systems to optimize research and manufacturing workflows.

Novartis France Tech Stack

Novartis France uses 8 technology products and services including MATLAB, Qlik, Qlik Sense, and more. Explore Novartis France's tech stack below.

  • MATLAB
    Advanced Analytics And Data Science
  • Qlik
    Business Intelligence
  • Qlik Sense
    Business Intelligence
  • SAP
    Customer Relationship Management
  • Vue.js
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • Python
    Programming Languages
  • C++
    Programming Languages

Media & News

Novartis France's Email Address Formats

Novartis France uses at least 2 format(s):
Novartis France Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%
First.Last@novartis.frJohn.Doe@novartis.fr
100%

Frequently Asked Questions

Where is Novartis France's headquarters located?

Minus sign iconPlus sign icon
Novartis France's main headquarters is located at Rueil-malmaison, Île-de-france 92500 France. The company has employees across 3 continents, including EuropeNorth AmericaAfrica.

What is Novartis France's official website and social media links?

Minus sign iconPlus sign icon
Novartis France's official website is novartis.fr and has social profiles on LinkedIn.

What is Novartis France's SIC code NAICS code?

Minus sign iconPlus sign icon
Novartis France's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Novartis France have currently?

Minus sign iconPlus sign icon
As of May 2026, Novartis France has approximately 544 employees across 3 continents, including EuropeNorth AmericaAfrica. Key team members include Head Learning & Development: N. G. D.Head Data Governance Infra & Tools: P. P.Head Ethics Risk & Compliance (erc) Operational Excellence / Deputy Head Erc: J. P.. Explore Novartis France's employee directory with LeadIQ.

What industry does Novartis France belong to?

Minus sign iconPlus sign icon
Novartis France operates in the Pharmaceutical Manufacturing industry.

What technology does Novartis France use?

Minus sign iconPlus sign icon
Novartis France's tech stack includes MATLABQlikQlik SenseSAPVue.jsModernizrPythonC++.

What is Novartis France's email format?

Minus sign iconPlus sign icon
Novartis France's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis France email formats with LeadIQ.

When was Novartis France founded?

Minus sign iconPlus sign icon
Novartis France was founded in 1997.

Novartis France

Pharmaceutical ManufacturingÎle-de-france, France501-1000 Employees

Novartis France operates within the pharmaceutical manufacturing sector, focusing on innovative medicines aimed at improving and extending patients’ lives. Its work touches a global patient base, with products designed to address serious illnesses and support healthcare professionals in managing complex conditions. Based in Rueil-Malmaison, Île-de-France, the company is part of a broader international pharmaceutical landscape and engages in activities that strengthen the development and production of advanced therapies.
The organization serves a professional market that includes patients and healthcare providers, emphasizing solutions that enable monitoring, rehabilitation, and treatment of chronic diseases. Its France-based operations form part of Novartis’ broader network in Europe and beyond, expanding capabilities in areas such as advanced therapies and collaborations across the health ecosystem. A notable recent development involves partnerships and expansions connected to its research and manufacturing footprint, reflecting ongoing efforts to advance therapeutic options.

Section iconCompany Overview

Headquarters
Rueil-malmaison, Île-de-france 92500 France
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
501-1000

Section iconFunding & Financials

  • $1M$10M

    Novartis France's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Novartis France's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.